Garrigue-Antar L, Barker C, Kadler K E
Wellcome Trust Centre for Cell-Matrix Research, School of Biological Sciences, University of Manchester, 2.205 Stopford Building, Oxford Road, Manchester M13 9PT, United Kingdom.
J Biol Chem. 2001 Jul 13;276(28):26237-42. doi: 10.1074/jbc.M010814200. Epub 2001 Mar 29.
Bone morphogenetic protein (BMP)-1, which belongs to the tolloid subgroup of astacin-like zinc metalloproteinases, cleaves the C-propeptides of procollagen at the physiologic site and is, therefore, a procollagen C-proteinase (PCP). Cleavage occurs between a specific alanine or glycine residue (depending on the procollagen chain) and an invariant aspartic acid residue in each of the three chains of procollagen. To learn more about how BMP-1 exhibits PCP activity we mapped the primary structure of BMP-1 onto the x-ray crystal structure of astacin and identified residues in the metalloproteinase domain of BMP-1 for subsequent site-directed mutagenesis studies. Recombinant wild-type and mutant BMP-1 were expressed in COS-7 cells and assayed for PCP activity using type I procollagen as the substrate. We showed that substitution of alanine for Glu(94), which occurs in the HEXXH zinc-binding motif of BMP-1, abolishes PCP activity. Furthermore, mutation of residues Lys(87) and Lys(176), which are located in the S1' pocket of the enzyme and are therefore adjacent to the P1' residue in the substrate, reduced the proteolytic activity of BMP-1 by approximately 50%. A surprising observation was that mutation of Cys(66) reduced the activity to 20%, suggesting that this residue is crucial for activity. Further experiments showed that Cys(66) and Cys(63), which are located in the tolloid-specific sequence Cys(63)-Gly(64)-Cys(65)-Cys(66) in the active site, most likely form a disulfide bridge.
骨形态发生蛋白(BMP)-1属于类astacin锌金属蛋白酶的tolloid亚组,在生理位点切割前胶原的C-前肽,因此是一种前胶原C蛋白酶(PCP)。切割发生在特定的丙氨酸或甘氨酸残基(取决于前胶原链)与前胶原三条链中每条链上不变的天冬氨酸残基之间。为了更多地了解BMP-1如何表现出PCP活性,我们将BMP-1的一级结构映射到astacin的X射线晶体结构上,并确定了BMP-1金属蛋白酶结构域中的残基,用于后续的定点诱变研究。重组野生型和突变型BMP-1在COS-7细胞中表达,并以前胶原I型为底物检测PCP活性。我们发现,将BMP-1的HEXXH锌结合基序中的Glu(94)替换为丙氨酸会消除PCP活性。此外,位于酶的S1'口袋中且因此与底物中的P1'残基相邻的Lys(87)和Lys(176)残基的突变使BMP-1的蛋白水解活性降低了约50%。一个惊人的发现是,Cys(66)的突变将活性降低到20%,表明该残基对活性至关重要。进一步的实验表明,位于活性位点的tolloid特异性序列Cys(63)-Gly(64)-Cys(65)-Cys(66)中的Cys(66)和Cys(63)很可能形成二硫键。